Technical Analysis for GWPH - GW Pharmaceuticals Plc

Grade Last Price % Change Price Change
grade A 183.62 -0.58% -1.07
GWPH closed down 0.58 percent on Friday, May 24, 2019, on 76 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical GWPH trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Multiple of Ten Bullish Other -0.58%
New 52 Week Closing High Bullish -1.92%
Up 3 Days in a Row Strength -1.92%
MACD Bullish Signal Line Cross Bullish -0.21%
Multiple of Ten Bullish Other -0.21%
Gapped Up Strength -0.21%
20 DMA Support Bullish 2.65%
MACD Bearish Signal Line Cross Bearish 4.90%
Multiple of Ten Bearish Other 4.90%

Older signals for GWPH ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
GW Pharmaceuticals plc, together with its subsidiaries, engages in the research, development, and commercialization of a range of cannabinoid prescription medicines. The company primarily offers Sativex, an oromucosal spray for the treatment of MS symptoms, cancer pain, and neuropathic pain. It also focuses on the Phase III clinical development program of Sativex for use in treatment of cancer pain. In addition, the company has two product candidates in Phase II trials in the field of diabetes and inflammation, as well as pre-clinical research programmes evaluating the use of selected cannabinoids for the treatment of glioma, epilepsy, and psychiatric illness. It has a strategic alliance with Otsuka Pharmaceutical Co. Ltd. The company operates in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Salisbury, the United Kingdom.
Health Cancer Pharmaceutical Industry Pain Drugs Diabetes Treatment Of Cancer Medication Inflammation Pharmaceutical Industry In China Pharmaceuticals Policy Cannabis Epilepsy Glioma Cannabinoids Neuropathic Pain
Is GWPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 196.0
52 Week Low 90.14
Average Volume 416,713
200-Day Moving Average 147.26
50-Day Moving Average 170.9834
20-Day Moving Average 178.411
10-Day Moving Average 180.293
Average True Range 6.8243
ADX 19.2
+DI 27.8924
-DI 18.5984
Chandelier Exit (Long, 3 ATRs ) 175.5271
Chandelier Exit (Short, 3 ATRs ) 177.7729
Upper Bollinger Band 189.6214
Lower Bollinger Band 167.2006
Percent B (%b) 0.73
BandWidth 12.566938
MACD Line 4.1896
MACD Signal Line 3.8246
MACD Histogram 0.3649
Fundamentals Value
Market Cap 4.66 Billion
Num Shares 25.4 Million
EPS -5.64
Price-to-Earnings (P/E) Ratio -32.56
Price-to-Sales 253.36
Price-to-Book 6.23
PEG Ratio 0.33
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 192.91
Resistance 3 (R3) 193.23 190.46 191.36
Resistance 2 (R2) 190.46 188.10 190.30 190.84
Resistance 1 (R1) 187.04 186.63 185.66 186.72 190.33
Pivot Point 184.27 184.27 183.58 184.11 184.27
Support 1 (S1) 180.85 181.91 179.47 180.53 176.91
Support 2 (S2) 178.08 180.44 177.92 176.40
Support 3 (S3) 174.66 178.08 175.88
Support 4 (S4) 174.34